Market Cap 33.21B
Revenue (ttm) 23.63B
Net Income (ttm) 509.67M
EPS (ttm) N/A
PE Ratio 16.53
Forward PE 13.47
Profit Margin 2.16%
Debt to Equity Ratio 0.20
Volume 21,600
Avg Vol 62,098
Day's Range N/A - N/A
Shares Out 2.25B
Stochastic %K 93%
Beta 0.75
Analysts Strong Sell
Price Target $14.96

Company Profile

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosi...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 49 6172 6080
Address:
Else-Kröner-Straße 1, Bad Homburg vor der Höhe, Germany
Latest News on FSNUY
No data available.